FriedL.F., BernardiniJ., JohnstonJ.R., PirainoB.Peritonitis influences mortality in peritoneal dialysis patients.J Am Soc Nephrol1996; 7: 2176–82.
2.
WoodrowG., TurneyJ.H., BrownjohnA.M.Technique failure in peritoneal dialysis and its impact on patient survival.Perit Dial Int1997; 17: 360–4.
3.
ChoiP., NematiE., BanerjeeA., PrestonE., LevyJ., BrownE.Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization.Am J Kidney Dis2004; 43: 103–11.
4.
SzetoC.C., ChowK.M., WongT.Y., LeungC.B., LiP.K.Conservative management of polymicrobial peritonitis complicating peritoneal dialysis—a series of 140 consecutive cases.Am J Med2002; 113: 728–33.
5.
BaystonR., AndrewsM., RiggK., SheltonA.Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis.Perit Dial Int1999; 19: 550–5.
6.
BunkeC.M., BrierM.E., GolperT.A.Outcomes of single organism peritonitis in peritoneal dialysis: gram-negatives versus gram-positives in the Network 9 Peritonitis Study.Kidney Int1997; 52: 524–9.
7.
PirainoB., BernardiniJ., SorkinM.The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1986; 8: 436–40.
8.
PirainoB., BernardiniJ., SorkinM.Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis.Am J Kidney Dis1989; 13: 365–9.
9.
JohnsonD.W., DentH., HawleyC.M., McDonaldS.P., RosmanJ.B., BrownF.G.Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.Am J Kidney Dis2009; 53: 290–7.
10.
KeaneW.F., EverettE.D., GolperT.A., GokalR., HalstensonC., KawaguchiY.Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis.Perit Dial Int1993; 13: 14–28.
BorgD., ShettyA., WilliamsD., FaberM.D.Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.Adv Perit Dial2003; 19: 202–5.
15.
Diaz-BuxoJ.A., WickG.S., PesichA.A.Using CQI techniques for managing infections in PD patients.Nephrol News Issues1998; 12: 22–4.
16.
SchaeferF., KandertM., FenebergR.Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children.Perit Dial Int2002; 22: 234–8.
17.
LiP.K., LawM.C., ChowK.M., ChanW.K., SzetoC.C., ChengY.L.Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study.Am J Kidney Dis2002; 40: 373–80.
18.
KimD.K., YooT.H., RyuD.R., XuZ.G., KimH.J., ChoiK.H.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.Perit Dial Int2004; 24: 424–32.
19.
AbrahamG., SavinE., AyiomamitisA., IzattS., VasS.I., MatthewsR.E.Natural history of exit-site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Bull1988; 8: 211–16.
20.
GonthierD., BernardiniJ., HolleyJ.L., PirainoB.Erythema: does it indicate infection in a peritoneal catheter exit site?Adv Perit Dial1992; 8: 230–3.
BunkeM., BrierM.E., GolperT.A.Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study.Am J Kidney Dis1995; 25: 769–74.
27.
KazmiH.R., RaffoneF.D., KligerA.S., FinkelsteinF.O.Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol1992; 2: 1498–501.
28.
JuergensenP.H., FinkelsteinF.O., BrennanR., SantacroceS., AhernM.J.Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study.Am J Kidney Dis1988; 11: 413–17.
29.
FillastreJ.P., LeroyA., MoulinB., DhibM., Borsa-LebasF., HumbertG.Pharmacokinetics of quinolones in renal insufficiency.J Antimicrob Chemother1990; 26(Suppl B): 51–60.
30.
HardyD.J., GuayD.R., JonesR.N.Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.Diagn Microbiol Infect Dis1992; 15: 39–53.
31.
American Thoracic Society; CDC; Infectious Diseases Society of America.Treatment of tuberculosis.MMWR Recomm Rep2003; 52(RR-11): 1–77.
32.
SchifflH., MuckeC., LangS.M.Exit-site infections by non-diphtheria corynebacteria in CAPD.Perit Dial Int2004; 24: 454–9.
33.
KwanT.H., TongM.K., SiuY.P., LeungK.T., LukS.H., CheungY.K.Ultrasonography in the management of exit site infections in peritoneal dialysis patients.Nephrology (Carlton)2004; 9: 348–52.
34.
LuiS.L., LiF.K., LoC.Y., LoW.K.Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.Adv Perit Dial2000; 16: 195–7.
35.
PosthumaN., BorgsteinP.J., EijsboutsQ., ter WeeP.M.Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis.Nephrol Dial Transplant1998; 13: 700–3.
36.
CancariniG.C., ManiliL., BrunoriG., CameriniC., ZubaniR., ColombritaD.Simultaneous catheter replacement/removal during infectious complications in peritoneal dialysis.Adv Perit Dial1994; 10: 210–13.
37.
SwartzR., MessanaJ., ReynoldsJ., RanjitU.Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.Kidney Int1991; 40: 1160–5.
38.
VychytilA., LorenzM., SchneiderB., HorlW.H., Haag-WeberM.New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.J Am Soc Nephrol1998; 9: 290–6.
39.
LuiS.L., YipT., TseK.C., LamM.F., LaiK.N., LoW.K.Treatment of refractory Pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter.Perit Dial Int2005; 25: 560–3.
40.
YoshinoA., HondaM., IkedaM., TsuchidaS., HatayaH., SakazumeS.Merit of the cuff-shaving procedure in children with chronic infection.Pediatr Nephrol2004; 19: 1267–72.
41.
CervelliM.J.The Renal Drug Reference Guide.Adelaide: Kidney Health Australia; 2007.
GouldI.M., CasewellM.W.The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis.J Hosp Infect1986; 7: 155–60.
44.
BetjesM.G., TukC.W., VisserC.E., ZemelD., KredietR.T., AriszL.Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis.Nephrol Dial Transplant1994; 9: 684–92.
45.
FlaniganM.J., FreemanR.M., LimV.S.Cellular response to peritonitis among peritoneal dialysis patients.Am J Kidney Dis1985; 6: 420–4.
46.
FusshollerA., zur NiedenS., GrabenseeB., PlumJ.Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.J Am Soc Nephrol2002; 13: 1055–60.
RocklinM.A., TeitelbaumI.Noninfectious causes of cloudy peritoneal dialysate.Semin Dial2001; 14: 37–40.
49.
ToureF., LavaudS., MohajerM., LavaudF., CanivetE., NguyenP.Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.Kidney Int2004; 65: 654–60.
50.
WolfsonM., PirainoB., HamburgerR.J., MortonAR; Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40: 1055–65.
51.
PosthumaN., ter WeeP., DonkerA.J., DekkerH.A., OeP.L., VerbrughH.A.Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.Perit Dial Int1999; 19: 334–42.
52.
GokalR., MistryC.D., PeersE.M.Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory dialysis.Perit Dial Int1995; 15: 226–30.
53.
AlfaM.J., DegagneP., OlsonN., HardingG.K.Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles.J Clin Microbiol1997; 35: 862–6.
54.
SewellD.L., GolperT.A., HulmanP.B., ThomasC.M., WestL.M., KubeyW.Y.Comparison of large volume culture to other methods for isolation of microorganisms from dialysate.Perit Dial Int1990; 10: 49–52.
55.
LyeW.C., WongP.L., LeongS.O., LeeE.J.Isolation of organisms in CAPD peritonitis: a comparison of two techniques.Adv Perit Dial1994; 10: 166–8.
AzapO.K., TimurkaynakF., SezerS., CagirU., YaparG., ArslanH.Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis.Transplant Proc2006; 38: 411–12.
58.
ParkS.J., LeeJ.Y., TakW.T., LeeJ.H.Using reagent strips for rapid diagnosis of peritonitis in peritoneal dialysis patients.Adv Perit Dial2005; 21: 69–71.
59.
AkmanS., UygunV., GuvenA.G.Value of the urine strip test in the early diagnosis of bacterial peritonitis.Pediatr Int2005; 47: 523–7.
60.
Nguyen-KhacE., CadranelJ.F., ThevenotT., NousbaumJ.B.Review Article: The utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients.Aliment Pharmacol Ther2008; 28: 282–8.
61.
YooT.H., ChangK.H., RyuD.R., KimJ.S., ChoiH.Y., ParkH.C.Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis.Am J Nephrol2006; 26: 115–20.
62.
JohnsonG., WilksM., WarwickS., MillarM.R., FanS.L.Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture methods.J Nephrol2006; 19: 45–9.
63.
RoY., HamadaC., IoH., HayashiK., HiraharaI., TominoY.Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit.J Clin Lab Anal2004; 18: 224–30.
64.
OtaK., MaruyamaH., IinoN., NakamuraG., ShimotoriM., TanabeY.Rapid detection of causative pathogen of peritonitis using in-situ hybridization in a patient with continuous ambulatory peritoneal dialysis.J Infect Chemother2007; 13: 273–5.
65.
SchaeferF., KlausG., Muller-WiefelD.E., MehlsO.Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).J Am Soc Nephrol1999; 10: 136–45.
66.
Van BiesenW., VanholderR., VogelaersD., PelemanR., VerschraegenG., VijtD.The need for a center-tailored treatment protocol for peritonitis.Perit Dial Int1998; 18: 274–81.
67.
Van BiesenW., VeysN., VanholderR., LameireN.Peritoneal dialysis-related peritonitis: the art of rope-dancing.Nephrol Dial Transplant2002; 17: 1878–82.
68.
KanG.W., ThomasM.A., HeathC.H.A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?Perit Dial Int2003; 23: 465–8.
69.
WongK.M., ChanY.H., CheungC.Y., ChakW.L., ChoiK.S., LeungS.H.Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis associated peritonitis.Am J Kidney Dis2001; 38: 127–31.
70.
VasS., BargmanJ., OreopoulosD.Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics.Perit Dial Int1997; 17: 91–4.
71.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Once daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.Adv Perit Dial1999; 15: 213–16.
72.
SheminD., MaazD., St PierreD., KahnS.I., ChazanJ.A.Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.Am J Kidney Dis1999; 34: 14–20.
73.
SinghalM.K., BhaskaranS., VidgenE., BargmanJ.M., VasS.I., OreopoulosD.G.Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.Perit Dial Int2000; 20: 429–38.
74.
ShinS.K., NohH., KangS.W., SeoB.J., LeeI.H., SongH.Y.Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 138–42.
75.
MulhernJ.G., BradenG.L., O'SheaM.H., MaddenR.L., LipkowitzG.S., GermainM.J.Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.Am J Kidney Dis1995; 25: 611–15.
76.
LiP.K., IpM., LawM.C., SzetoC.C., LeungC.B., WongT.Y.Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis.Perit Dial Int2000; 20: 232–4.
77.
KhairullahQ., ProvenzanoR., TayebJ., AhmadA., BalakrishnanR., MorrisonL.Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.Perit Dial Int2002; 22: 339–44.
78.
FieldingR.E., ClemengerM., GoldbergL., BrownE.A.Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.Perit Dial Int2002; 22: 345–9.
79.
ElwellR.J., BailieG.R., ManleyH.J.Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.Perit Dial Int2000; 20: 694–8.
DooleyD.P., TylerJ.R., WorthamW.G., HarrisonL.S., StarnesW.F.Jr., CollinsG.R.Prolonged stability of antimicrobial activity in peritoneal dialysis solutions.Perit Dial Int2003; 23: 58–62.
82.
FlaniganM.J., LimV.S.Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.Perit Dial Int1991; 11: 31–7.
ManleyH.J., BailieG.R., AsherR.D., EiseleG., FryeR.F.Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 65–70.
85.
ManleyH.J., BailieG.R.Treatment of peritonitis in APD: pharmacokinetic principles.Semin Dial2002; 15: 418–21.
86.
ManleyH.J., BridwellD.L., ElwellR.J., BailieG.R.Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin.Perit Dial Int2003; 23: 469–74.
87.
GucekA., BrenA.F., HergouthV., LindicJ.Cefazolin and netilmicin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.Adv Perit Dial1997; 13: 218–20.
88.
ZelenitskyS., BarnsL., FindlayI., AlfaM., ArianoR., FineA.Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998.Am J Kidney Dis2000; 36: 1009–13.
89.
LyeW.C., WongP.L., van der StraatenJ.C., LeongS.O., LeeE.J.A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.Adv Perit Dial1995; 11: 179–81.
90.
LyeW.C., van der StraatenJ.C., LeongS.O., SivaramanP., TanS.H., TanC.C.Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.Perit Dial Int1999; 19: 357–60.
91.
BakerR.J., SeniorH., ClemengerM., BrownE.A.Empirical aminoglycosides for peritonitis do not affect residual renal function.Am J Kidney Dis2003; 41: 670–5.
LuiS.L., ChengS.W., NgF., NgS.Y., WanK.M., YipT.Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.Kidney Int2005; 68: 2375–80.
94.
GoffinE., HerbietL., PouthierD., PochetJ.M., LafontaineJ.J., ChristopheJ.L.Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.Perit Dial Int2004; 24: 433–9.
95.
LimaR.C., BarreiraA., CardosoF.L., LimaM.H., LeiteMJr.Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up.Perit Dial Int2007; 27: 56–60.
96.
KobayashiK., NakamotoH., OkadaS., HoshitaniK., UchidaK., ArimaH.Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.Adv Perit Dial2006; 22: 65–8.
97.
LivermoreD.M.Has the era of untreatable infections arrived?J Antimicrob Chemother2009; 64(Suppl 1): i29–36.
98.
LeungC.B., SzetoC.C., ChowK.M., KwanB.C., WangA.Y., LuiS.F.Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis—a randomized controlled trial.Perit Dial Int2004; 24: 440–6.
99.
ChengI.K., FangG.X., ChauP.Y., ChanT.M., TongK.L., WongA.K.A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.Perit Dial Int1998; 18: 371–5.
100.
LyeW.C., LeeE.J., van der StraatenJ.Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.Perit Dial Int1993; 13(Suppl 2): S348–50.
101.
YeungS.M., WalkerS.E., TailorS.A., AwdishuL., TobeS., YassaT.Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.Perit Dial Int2004; 24: 447–53.
102.
ChanM.K., ChengI.K., NgW.S.A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1990; 15: 155–9.
103.
Perez-FontanM., RosalesM., FernandezF., MoncalianJ., Fernandez-RiveraC., AlonsoA.Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.Perit Dial Int1991; 11: 233–6.
104.
BoeschotenE.W., RietraP.J., KredietR.T., VisserM.J., AriszL.CAPD peritonitis: a prospective randomized trial of oral versus intraperitoneal treatment with cephradine.J Antimicrob Chemother1985; 16: 789–97.
105.
TongM.K., LeungK.T., SiuY.P., LeeK.F., LeeH.K., YungC.Y.Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.J Nephrol2005; 18: 204–8.
106.
WilliamsonJ.C., VollesD.F., LynchP.L., RogersP.D., HaverstickD.M.Stability of cefepime in peritoneal dialysis solution.Ann Pharmacother1999; 33: 906–9.
107.
VogesM., FaictD., LechienG., TaminneM.Stability of drug additives in peritoneal dialysis solutions in a new container.Perit Dial Int2004; 24: 590–5.
108.
BlundenM., ZeitlinD., AshmanN., FanS.L.Single UK centre experience on the treatment of PD peritonitis–antibiotic levels and outcomes.Nephrol Dial Transplant2007; 22: 1714–19.
109.
BoyceN.W., WoodC., ThomsonN.M., KerrP., AtkinsR.C.Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis—a prospective, randomized comparison of intermittent v continuous therapy.Am J Kidney Dis1988; 12: 304–6.
110.
LowC.L., BailieG.R., EvansA., EiseleG., VeneziaR.A.Pharmacokinetics of once-daily IP gentamicin in CAPD patients.Perit Dial Int1996; 16: 379–84.
111.
LowC.L., GopalakrishnaK., LyeW.C.Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol2000; 11: 1117–21.
112.
ManleyH.J., BailieG.R., FryeR., HessL.D., McGoldrickM.D.Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.J Am Soc Nephrol2000; 11: 1310–16.
HuenS.C., HallI., TopalJ., MahnensmithR.L., BrewsterU.C., Abu-AlfaA.K.Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.Am J Kidney Dis2009; 54: 538–41.
116.
PrasadK.N., PrasadN., GuptaA., SharmaR.K., VermaA.K., AyyagariA.Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience.J Infect2004; 48: 96–101.
117.
WangA.Y., YuA.W., LiP.K., LamP.K., LeungC.B., LaiK.N.Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center.Am J Kidney Dis2000; 36: 1183–92.
118.
GoldieS.J., Kiernan-TroidleL., TorresC., Gorban-BrennanN., DunneD., KligerA.S.Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.Am J Kidney Dis1996; 28: 86–91.
119.
ZarubaK., PetersJ., JungbluthH.Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience [Published erratum appears in Am J Kidney Dis 1991; 17:726].Am J Kidney Dis1991; 17: 43–6.
120.
RobitailleP., MerouaniA., ClermontM.J., HebertE.Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience.Perit Dial Int1995; 15: 77–9.
121.
ThodisE., VasS.I., BargmanJ.M., SinghalM., ChuM., OreopoulosD.G.Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis [see Comment].Perit Dial Int1998; 18: 583–9.
122.
WadhwaN.K., SuhH., CabraldaT.Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.Adv Perit Dial1996; 12: 189–91.
123.
WilliamsP.F., MoncrieffN., MarriottJ.No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients.Perit Dial Int2000; 20: 352–3.
124.
LoW.K., ChanC.Y., ChengS.W., PoonJ.F., ChanD.T., ChengI.K.A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis.Am J Kidney Dis1996; 28: 549–52.
125.
WongP.N., LoK.Y., TongG.M., ChanS.F., LoM.W., MakS.K.Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD.Perit Dial Int2007; 27: 531–6.
126.
GadallahM.F., TamayoA., SandbornM., RamdeenG., MolesK.Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients.Adv Perit Dial2000; 16: 233–6.
127.
InnesA., BurdenR.P., FinchR.G., MorganA.G.Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial.Nephrol Dial Transplant1994; 9: 797–9.
128.
WilliamsA.J., BoletisI., JohnsonB.F., RafteryA.T., CohenG.L., MoorheadP.J.Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.Perit Dial Int1989; 9: 65–7.
129.
CobanE., OzdoganM., TuncerM., BozcukH., ErsoyF.The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.J Nephrol2004; 17: 427–30.
130.
KrishnanM., ThodisE., IkonomopoulosD., VidgenE., ChuM., BargmanJ.M.Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Perit Dial Int2002; 22: 573–81.
131.
SzetoC.C., ChowK.M., WongT.Y., LeungC.B., WangA.Y., LuiS.F.Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal.J Am Soc Nephrol2002; 13: 1040–5.
132.
ChowK.M., SzetoC.C., CheungK.K., LeungC.B., WongS.S., LawM.C.Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.Clin J Am Soc Nephrol2006; 1: 768–73.
133.
SzetoC.C., KwanB.C., ChowK.M., LawM.C., PangW.F., ChungK.Y.Recurrent and relapsing peritonitis: causative organisms and response to treatment.Am J Kidney Dis2009; 54: 702–10. Epub 4 Jul 2009 as doi:10.1053/j.ajkd.2009.04.032.
134.
FinkelsteinE.S., JekelJ., TroidleL., Gorban-BrennanN., FinkelsteinF.O., BiaF.J.Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis.Am J Kidney Dis2002; 39: 1278–86.
135.
DasguptaM.K., WardK., NobleP.A., LarabieM., CostertonJ.W.Development of bacterial biofilms on Silastic catheter materials in peritoneal dialysis fluid.Am J Kidney Dis1994; 23: 709–16.
136.
ReadR.R., EberweinP., DasguptaM.K., GrantS.K., LamK., NickelJ.C.Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface.Kidney Int1989; 35: 614–21.
137.
SengP., DrancourtM., GourietF., LaS.B., FournierP.E., RolainJ.M.Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time of flight mass spectrometry.Clin Infect Dis2009; 49: 543–51.
138.
van VeenS.Q., ClaasE.C., KuijperE.J.High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.J Clin Microbiol2010; 48: 900–7.
139.
DupontC., Sivadon-TardyV., BilleE., DauphinB., BerettiJ., AlvarezA.Identification of clinical coagulase negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems.Clin Microbiol Infect. Epub 2 Sep 2009 as doi:10:1111/j.1469-0691.2009.03036.x.
140.
Munoz de BustilloE., AguileraA., JimenezC., BajoM.A., SanchezC., SelgasR.Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD.Perit Dial Int1997; 17: 392–5.
141.
O'SheaS., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases.BMC Nephrol2009; 10: 19.
142.
ShuklaA., AbreuZ., BargmanJ.M.Streptococcal PD peritonitis–a 10-year review of one centre's experience.Nephrol Dial Transplant2006; 21: 3545–9.
143.
EdeyM., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases.Nephrol Dial Transplant2010; 25: 1272–8. Epub 30 Nov 2009 as doi:10.1093/ndt/gfp641.
144.
AriasC.A., MurrayB.E.Emergence and management of drug-resistant enterococcal infections.Expert Rev Anti Infect Ther2008; 6: 637–55.
145.
TroidleL., KligerA.S., Gorban-BrennanN., FikrigM., GoldenM., FinkelsteinF.O.Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.Kidney Int1996; 50: 1368–72.
146.
AllcockN.M., KruegerT.S., ManleyH.J., KumarV.K., AbdallahJ.Linezolid disposition during peritonitis: a case report.Perit Dial Int2004; 24: 68–70.
147.
LynnW.A., ClutterbuckE., WantS., MarkidesV., LaceyS., RogersT.R.Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.Lancet1994; 344(8928): 1025–6.
LyeW.C., LeongS.O., van der StraatenJ., LeeE.J.Staphylococcus aureus CAPD-related infections are associated with nasal carriage.Adv Perit Dial1994; 10: 163–5.
GovindarajuluS., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 503 cases.Perit Dial Int2010; 30: 311–19. Epub 26 Feb 2010 as doi:10.3747/pdi.2008.00258.
152.
BarracloughK., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases.Nephrol Dial Transplant2009; 24: 3834–9. Epub 2 Jul 2009 as doi:10.1093/ndt/gfp322.
153.
SzetoC.C., ChowK.M., ChungK.Y., KwanB.C., LeungC.B., LiP.K.The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species.Nephrol Dial Transplant2005; 20: 2793–6.
FahimM., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment and outcomes in 435 cases.Am J Kidney Dis2010; 55: 690–7. Epub 29 Jan 2010 as doi:10.1053/j.ajkd.2009.11.015.
156.
SzetoC.C., ChowK.M., LeungC.B., WongT.Y., WuA.K., WangA.Y.Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases.Kidney Int2001; 59: 2309–15.
157.
SivaB., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases.Clin J Am Soc Nephrol2009; 4: 957–64.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Differing outcomes of gram-positive and gram-negative peritonitis.Am J Kidney Dis1998; 32: 623–8.
160.
SepandjF., CeriH., GibbA., ReadR., OlsonM.Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis.Perit Dial Int2004; 24: 65–7.
161.
Valdes-SotomayorJ., CirugedaA., BajoM.A., del PesoG., EscuderoE., Sanchez-TomeroJ.A.Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing.Perit Dial Int2003; 23: 450–5.
162.
PrasadN., GuptaA., SharmaR.K., PrasadK.N., GulatiS., SharmaA.P.Outcome of gram-positive and gram-negative peritonitis in patients on continuous ambulatory peritoneal dialysis: a single center experience.Perit Dial Int2003; 23(Suppl 2): S144–7.
163.
SzetoC.C., ChowV.C., ChowK.M., LaiR.W., ChungK.Y., LeungC.B.Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases.Kidney Int2006; 69: 1245–52.
164.
ZurowskaA., FenebergR., WaradyB.A., ZimmeringM., MonteverdeM., TestaS.Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.Am J Kidney Dis2008; 51: 455–62.
165.
TzanetouK., TriantaphillisG., TsoutsosD., PetropoulouD., GanterisG., Malamou-LadaE.Stenotrophomonas maltophilia peritonitis in CAPD patients: susceptibility of antibiotics and treatment outcome: a report of five cases.Perit Dial Int2004; 24: 401–4.
166.
SteinerR.W., HalaszN.A.Abdominal catastrophes and other unusual events in continuous ambulatory peritoneal dialysis patients.Am J Kidney Dis1990; 15: 1–7.
HolleyJ.L., BernardiniJ., PirainoB.Polymicrobial peritonitis in patients on continuous peritoneal dialysis.Am J Kidney Dis1992; 19: 162–6.
173.
HarwellC.M., NewmanL.N., CachoC.P., MulliganD.C., SchulakJ.A., FriedlanderM.A.Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis.Perit Dial Int1997; 17: 586–94.
174.
FaberM.D., YeeJ.Diagnosis and management of enteric disease and abdominal catastrophe in peritoneal dialysis patients with peritonitis.Adv Chronic Kidney Dis2006; 13: 271–9.
175.
BarracloughK., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.Am J Kidney Dis2010; 55: 121–31. Epub 22 Nov 2009 as doi:10.1053/j.ajkd.2009.08.020.
176.
MilesR., HawleyC.M., McDonaldS.P., BrownF.G., RosmanJ.B., WigginsK.J.Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients.Kidney Int2009; 76: 622–8.
177.
GhebremedhinB., BluemelA., NeumannK.H., KoenigB., KoenigW.Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.J Med Microbiol2009; 58: 678–82.
178.
SedlacekM., CotterJ.G., SuriawinataA.A., KanekoT.M., ZuckermanR.A., ParsonnetJ.Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.Am J Kidney Dis2008; 51: 302–6.
179.
Matuszkiewicz-RowinskaJ.Update on fungal peritonitis and its treatment.Perit Dial Int2009; 29(Suppl 2): S161–5.
FourtounasC., MarangosM., KalliakmaniP., SavidakiE., GoumenosD.S., VlachojannisJ.G.Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy.Nephrol Dial Transplant2006; 21: 236–7.
182.
AhnC., OhK.H., KimK., LeeK.Y., LeeJ.G., OhM.D.Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin.Perit Dial Int2003; 23: 362–7.
183.
AbrahamG., MathewsM., SekarL., SrikanthA., SekarU., SoundarajanP.Tuberculous peritonitis in a cohort of continuous ambulatory peritoneal dialysis patients.Perit Dial Int2001; 21(Suppl 3): S202–4.
184.
GuptaN., PrakashK.C.Asymptomatic tuberculous peritonitis in a CAPD patient.Perit Dial Int2001; 21: 416–17.
185.
HarroC., BradenG.L., MorrisA.B., LipkowitzG.S., MaddenR.L.Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis.Clin Infect Dis1997; 24: 955–7.
186.
LuiS.L., TangS., LiF.K., ChoyB.Y., ChanT.M., LoW.K.Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis.Am J Kidney Dis2001; 38: 1055–60.
LyeW.C.Rapid diagnosis of Mycobacterium tuberculous peritonitis in two continuous ambulatory peritoneal dialysis patients, using DNA amplification by polymerase chain reaction.Adv Perit Dial2002; 18: 154–7.
189.
OgutmenB., TuglularS., Al AhdabH., AkogluE., OzenerQ.Tuberculosis peritonitis with clear fluid accompanying systemic disseminated tuberculosis in a CAPD patient.Perit Dial Int2003; 23: 95–6.
MitraA., TeitelbaumI.Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines.Adv Perit Dial2003; 19: 255–9.
194.
WilliamsA.J., BoletisI., JohnsonB.F., RafteryA.T., CohenG.L., MoorheadP.J.Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.Perit Dial Int1989; 9: 65–7.
195.
TroidleL., Gorban-BrennanN., FinkelsteinF.O.Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis.Adv Perit Dial2005; 21: 98–101.
